Knowledge-driven approaches for the guidance of first-in-children dosing

DEVELOPMENTAL PHARMACOLOGY: NEONATES ARE NOT JUST SMALL ADULTS…

(2014) K. Allegaert et al.   ACTA CLINICA BELGICA

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

(2010) Richard Kahn et al.   LANCET

A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals

(2010) Thomas Peyret et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development

(2009) Masato Chiba et al.   AAPS Journal

Population pharmacokinetics and optimal design of paediatric studies for famciclovir

(2009) Kayode Ogungbenro et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling

(2009) Yasushi Shono et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Analysis of Nifedipine Absorption from Soft Gelatin Capsules Using PBPK Modeling and Biorelevant Dissolution Testing

(2009) Kirstin Thelen et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Optimizing Pediatric Dosing: A Developmental Pharmacologic Approach

(2009) Gail D Anderson et al.   PHARMACOTHERAPY

Population Pharmacokinetics of Fluconazole in Young Infants

(2008) K. C. Wade et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Human renal function maturation: a quantitative description using weight and postmenstrual age

(2008) Malin M. Rhodin et al.   PEDIATRIC NEPHROLOGY

The problems in scaling adult drug doses to children

(2007) T N Johnson   ARCHIVES OF DISEASE IN CHILDHOOD